Loading clinical trials...
Loading clinical trials...
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Conditions
Interventions
AXS-02
Placebo
Locations
61
United States
Achieve Clinical Research
Birmingham, Alabama, United States
Birmingham, Alabama, United States
Chandler, Arizona, United States
Phoenix, Arizona, United States
Hot Springs, Arkansas, United States
Anaheim, California, United States
Start Date
March 1, 2016
Primary Completion Date
December 1, 2020
Completion Date
December 1, 2020
Last Updated
January 10, 2019
NCT07364578
NCT06488144
NCT07058623
NCT06083480
NCT06955481
NCT06208631
Lead Sponsor
Axsome Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions